Compound Detail

CHEMBL1927246

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

COc1cc([C@@H]2c3cc4c(cc3[C@@H](NC(=O)/C=C/c3ccc([N+](=O)[O-])cc3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL1927246
Phase	Preclinical
Structure Type	MOL
InChI Key	RCZHORLHRVOEFS-SPMYTZGXSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

588.6

MW (Da)

4.15

ALogP

HBA

HBD

144.7

PSA (Å²)

0.18

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 5 meas. best 5.09

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
A549 CHEMBL392	IC50	5.09	5.09	8200.0	1
MCF7 CHEMBL387	IC50	5.0	5.0	10100.0	1
ACHN CHEMBL614519	IC50	4.89	4.89	12800.0	1
A-375 CHEMBL613859	IC50	4.84	4.84	14500.0	1
HT-29 CHEMBL384	IC50	4.74	4.74	18100.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
A549	IC50	=	8200.0	nM	5.09	Anticancer activity against human A549 cells after 48 hrs by MTT assay	22136907
MCF7	IC50	=	10100.0	nM	5.0	Anticancer activity against human MCF7 cells after 48 hrs by MTT assay	22136907
ACHN	IC50	=	12800.0	nM	4.89	Anticancer activity against human ACHN cells after 48 hrs by MTT assay	22136907
A-375	IC50	=	14500.0	nM	4.84	Anticancer activity against human A375 cells after 48 hrs by MTT assay	22136907
HT-29	IC50	=	18100.0	nM	4.74	Anticancer activity against human HT-29 cells after 48 hrs by MTT assay	22136907

PubMed	DOI	Target Context	# Activities
22136907	10.1016/j.ejmech.2011.11.024	A549	1
22136907	10.1016/j.ejmech.2011.11.024	A-375	1
22136907	10.1016/j.ejmech.2011.11.024	MCF7	1
22136907	10.1016/j.ejmech.2011.11.024	HT-29	1
22136907	10.1016/j.ejmech.2011.11.024	ACHN	1

Data from ChEMBL 36 via Core Engine